Abstract
Background: Myocardial Infarction (MI), a kind of heart deficiency, is the main cause of death and disability. Autophagy, a metabolic process for the degradation of damaged proteins or organelles, is important for cardiac functions and regulated by several miRNAs including miRNA- 101. The aim of this research was to investigate the effects of miR-101 in myocardial infarctioninduced injury and the related mechanisms.
Methods: MI model was induced by ligation of the left coronary artery. The in vitro model was established by hypoxia-induced H9c2 cells (rat myocardial cells). The overexpression of miR-101 was achieved by transfection. The expression of associated proteins was analyzed by Western blotting. The level of miR-101 was analyzed by reverse transcription-polymerase chain reaction (RTPCR). The target genes for miR-101 and the target sites were analyzed by TargetScan.
Results: The results showed that miR-101 was decreased in MI mice (P<0.01). Autophagy and apoptosis were increased in MI-induced injury (in vivo) and in hypoxia treated myocardial cells (in vitro) (P<0.01). miR-101 overexpression inhibited the increase of autophagy and apoptosis in mice and myocardial cells (P<0.01). DDIT4 was a target gene of miR-101 and expressed increasingly in MI-induced injury mice and hypoxia treated myocardial cells. miR-101 could negatively regulate the expression of DDIT4.
Conclusion: This research suggested that miR-101 attenuated- MI-induced injury by targeting DDIT4 to regulate autophagy, which indicated that miR-101 or DDIT4 may be potential therapeutic targets for heart injury.
Keywords: miRNA-101, myocardial infarction-induced injury, DNA damage-inducible transcript 4, autophagy, tissue, heart.
[http://dx.doi.org/10.1093/eurheartj/ehy655]
[http://dx.doi.org/10.1038/cdd.2008.163] [PMID: 19008922]
[http://dx.doi.org/10.1111/1440-1681.12309]
[http://dx.doi.org/10.1016/j.ajpath.2012.11.009]
[http://dx.doi.org/10.1111/jphp.12567]
[http://dx.doi.org/10.1161/01.RES.0000261924.76669.36] [PMID: 17332429]
[http://dx.doi.org/10.1016/j.ijcard.2017.06.054] [PMID: 28663047]
[http://dx.doi.org/10.3892/or.2015.4467]
[http://dx.doi.org/10.1186/s13046-016-0420-1]
[http://dx.doi.org/10.3390/molecules21111490] [PMID: 27834881]
[http://dx.doi.org/10.1161/hy02t2.102796]
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.094524] [PMID: 22811578]
[http://dx.doi.org/10.1371/journal.pone.0011397] [PMID: 20617180]
[http://dx.doi.org/10.21037/jtd.2016.08.93]
[http://dx.doi.org/10.1093/eurheartj/ehq013]
[http://dx.doi.org/10.12659/MSM.893540] [PMID: 26022377]
[http://dx.doi.org/10.1016/j.biocel.2015.06.005] [PMID: 26055514]